These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6473351)

  • 21. The action of the aminoglycosidic antibiotic gentamicin of the isolated rat diaphragm. Potentiation of the neuromuscular blocking activity of gentamicin during combined application with muscle relaxant agents and magnesium.
    Paradelis AG; Triantaphyllidis C; Fidani V; Logaras G
    Arzneimittelforschung; 1974 Nov; 24(11):1774-9. PubMed ID: 4480048
    [No Abstract]   [Full Text] [Related]  

  • 22. A study of the increased sensitivity of denervated and re-innervated muscle to depolarizing drugs.
    Maclagan J; Vrbová G
    J Physiol; 1966 Jan; 182(1):131-43. PubMed ID: 5937407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of so-called "depolarizing" and "repolarizing" substances on neuromuscular excitability].
    Quevauviller A; Levy JC
    Anesth Analg (Paris); 1967; 24(2):247-68. PubMed ID: 4383825
    [No Abstract]   [Full Text] [Related]  

  • 24. The actions of neuromuscular relaxants at hyperbaric pressures.
    Gountis-Bonikos C; Kendig JJ; Cohen EN
    Anesthesiology; 1977 Jul; 47(1):11-5. PubMed ID: 869244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of d-tubocurarine, pancuronium and atracurium on the responses of gastrocnemius and soleus muscles in the cat.
    Choi WW; Gergis SD; Sokoll MD
    Acta Anaesthesiol Scand; 1984 Dec; 28(6):608-11. PubMed ID: 6549246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species-dependent effect of neuromuscular blocking agents.
    Derkx FH; Bonta IL; Lagendijk A
    Eur J Pharmacol; 1971 Sep; 16(1):105-8. PubMed ID: 5157524
    [No Abstract]   [Full Text] [Related]  

  • 27. Monitoring of neuromuscular function.
    Ali HH; Savarese JJ
    Anesthesiology; 1976 Aug; 45(2):216-49. PubMed ID: 180849
    [No Abstract]   [Full Text] [Related]  

  • 28. Local electrographic responses to intrahippocampal d-tubocurarine and related neuromuscular blocking agents.
    Baker WW; Benedict F
    Proc Soc Exp Biol Med; 1967 Feb; 124(2):607-11. PubMed ID: 4225340
    [No Abstract]   [Full Text] [Related]  

  • 29. Lithium carbonate and neuromuscular blocking agents.
    Hill GE; Wong KC; Hodges MR
    Anesthesiology; 1977 Feb; 46(2):122-6. PubMed ID: 835845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromuscular pharmacology. A clinical update and commentary.
    Lee C; Katz RL
    Br J Anaesth; 1980 Feb; 52(2):173-88. PubMed ID: 6244842
    [No Abstract]   [Full Text] [Related]  

  • 31. An electrophysiological study of the effects of D-tubocurarine, atropine, and alpha-bungarotoxin on the cholinergic receptor in innervated and chronically denervated mammalian skeletal muscles.
    Lapa AJ; Albuquerque EX; Daly J
    Exp Neurol; 1974 May; 43(2):375-98. PubMed ID: 4826975
    [No Abstract]   [Full Text] [Related]  

  • 32. Succinylcholine and decamethonium: comparison of depolarization and desensitization.
    Gissen AJ; Nastuk WL
    Anesthesiology; 1970 Dec; 33(6):611-8. PubMed ID: 5477644
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental study on the neuromuscular blocking action of procaine amide.
    Galzigna L; Manani G; Mammano S; Gasparetto A; Deana R
    Agressologie; 1972; 13(2):107-16. PubMed ID: 4342790
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of neuromuscular blockade produced by atracurium in frog sartorius muscle.
    Wali FA
    Pharmacol Res Commun; 1985 Aug; 17(8):711-23. PubMed ID: 3876572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adaptation of the neuromuscular junction to chronic acetylcholinesterase inhibition due to phospholine treatment.
    Faff J; Bak W
    Arch Int Pharmacodyn Ther; 1981 Apr; 250(2):293-301. PubMed ID: 7271388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromuscular blocking agents and axial teratogenesis in the avian embryo. Can axial morphogenetic disorders by explained by pharmacological action upon muscle tissue?
    Meiniel R
    Teratology; 1981 Apr; 23(2):259-71. PubMed ID: 7196602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological studies of extraocular muscles.
    Katz RL; Eakins KE
    Invest Ophthalmol; 1967 Jun; 6(3):261-8. PubMed ID: 6026354
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on curare-like action of 2,2',2''-tripyridine in the mouse phrenic nerve-diaphragm.
    Lin-Shiau SY; Hsu KS; Fu WM
    Br J Pharmacol; 1992 May; 106(1):55-60. PubMed ID: 1504731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of facilitatory concentrations of decamethonium on the storage and release of transmitter at the neuromuscular junction of the cat.
    Blaer LC
    J Pharmacol Exp Ther; 1970 Dec; 175(3):664-72. PubMed ID: 5489921
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the neuromuscular effects of beta-diethylaminoethyl-diphenyl propylacetate hydrochloride (SKF-525-A).
    Suarez-Kurtz G; Paulo LG
    Arch Int Pharmacodyn Ther; 1968 May; 173(1):133-43. PubMed ID: 5661010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.